Fresenius SE & Co. KGaA buy t66wv33c
Summary
This prediction ended on 18.03.15 with a price of €55.30. The BUY prediction by t66wv33c finished with a performance of 11.71%. t66wv33c has 50% into this predictionFresenius is a German healthcare company listed on the Frankfurt and New York stock exchanges under the symbol FSNUF. The company is primarily engaged in the production and distribution of medical devices, pharmaceuticals, and services related to renal dialysis, critical care, and hospital operations. With over 290,000 employees and operations in more than 100 countries, Fresenius is one of the largest healthcare providers in the world. The company has experienced steady growth over the years, driven by its innovative product portfolio, strategic acquisitions, and a focus on operational efficiency.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Fresenius SE & Co. KGaA | 1.776% | 1.776% | 4.930% | -33.378% |
iShares Core DAX® | -3.033% | -0.013% | 11.953% | 15.609% |
iShares Nasdaq 100 | -3.554% | -2.546% | 30.128% | 44.540% |
iShares Nikkei 225® | -3.938% | 2.183% | 11.741% | 8.345% |
iShares S&P 500 | -1.517% | -0.882% | 25.752% | 42.388% |
Comments by t66wv33c for this prediction
In the thread Fresenius SE & Co. KGaA diskutieren
Defensive Aktie
Wichtiges Urteil
Privatkliniken mit einem hohen Anteil gesetzlich versicherter Patienten dürfen nach einem Urteil des Bundesfinanzhofs steuerlich nicht schlechter gestellt werden als öffentliche Kliniken. Hier kann der Kurs jetzt noch mal nachlegen. Zudem ist es eine defensive Aktie welche sich eher hält, wenn der DAX mal fällt.
Stopped prediction by t66wv33c for Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA
17.10.17
17.04.18
17.04.18